Precigen Inc (NAS:PGEN)
$ 1.4 0.07 (5.26%) Market Cap: 353.39 Mil Enterprise Value: 297.67 Mil PE Ratio: 0 PB Ratio: 3.59 GF Score: 45/100

Precigen Inc Business and Clinical Update Call Transcript

Apr 04, 2023 / 12:30PM GMT
Release Date Price: $1.03 (-8.04%)
Operator

Good morning, and welcome to the Precigen Business and Clinical Update Conference Call. (Operator Instructions) Please note, this event is being recorded.

I would now like to turn the conference over to Steven Harasym, Head of Investor Relations. Please go ahead.

Steven Harasym
Precigen, Inc. - VP & Head of IR

Thank you, Anthony. We are joined today by Dr. Helen Sabzevari, President and CEO of Precigen.

Before we begin, I'd like to remind you that during today's call, we will make various forward-looking statements. Investors are cautioned that our forward-looking statements are based on current expectations and are subject to risks and uncertainties that could cause actual results or outcomes to differ. Please read the safe harbor statement contained on our company filings as well as risk factors in our most recent SEC filings.

Helen, I'd like to turn the call over to you now. Thank you.

Helen Sabzevari
Precigen, Inc. - President, CEO & Director

Thank you, Steve, and thank you

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot